HEPATITIS AND RETROVIRUS

HBsAg Confirmatory Test

The HBsAg Confirmatory Test is an in vitro neutralization assay for confirmation of the presence of hepatitis B surface antigen (HBsAg) in human serum and plasma samples found repeatedly reactive for HBsAg by LIAISON XL MUREX HBsAg Quant or LIAISON HBsAg.

LIAISON XL Anti-HBs

The LIAISON XL Anti-HBs II assay uses chemiluminescence immunoassay (CLIA) technology for the quantitative determination of antibody to hepatitis B surface antigen (anti-HBs) in human serum or plasma samples. The test has to be performed on the LIAISON analyzer family.

LIAISON XL Anti-HBs Plus

The LIAISON XL Anti-HBs II assay uses chemiluminescence immunoassay (CLIA) technology for the quantitative determination of antibody to hepatitis B surface antigen (anti-HBs) in human serum or plasma samples. The test has to be performed on the LIAISON analyzer family.

LIAISON Anti-HBc

The LIAISON Anti-HBc assay uses chemiluminescent immunoassay (CLIA) technology for the qualitative determination of total antobodies to hepatitis B core antigen (anti-HBc) in human serum or plasma samples. The test has to be performed on the LIAISON analyzer family.

LIAISON HBc IgM 

The LIAISON HBc IgM assay uses chemiluminescence immunoassay (CLIA) technology for the qualitative determination of IgM immunoglobulim to hepatitis B core antigen (IgM anti-HBc) in human serum or plasma samples. The test has to be performed on the LIAISON analyzer family.

LIAISON HBeAg

The LIAISON HBeAg assay uses chemiluminescent immunoassay (CLIA) technology for the quantitative determination of e antigen of hepatitis B virus (HBeAg) in human serum or plasma samples. HBeAg quantification may allow follow up of replicative activity/response to treatment (e.g. interferon) (20). The test has to be performed on the LIAISON analyzer family.

LIAISON Anti-HBe

The LIAISON Anti-HBe assay uses chemiluminescence immunoassay (CLIA) technology for the qualitative determination of total antibodies to hepatitis B a antigen (anti-Bbe) in human serum or plasma samples. The test had to be perfomed on the LIAISON analyzer family.

LIAISON Anti-HAV

The LIAISON Anti-HAV assay uses chemiluminescence immunoassay (CLIA) technology for the qualitative determination of total antibodies to hepatitis A virus (anti-HAV) in human serum or plasma samples. The test has to be performed on the LIAISON analyzer family.

LIAISON HAV IgM

The LIAISON HAV IgM assay uses chemiluminescent immunoassay (CLIA) technology for the qualitative determination of IgM immunoglobulin to hepatitis A virus (IgM anti-HAV) in human serum or plasma samples. The test has to be performed on the LIAISON analyzer family.

HEPATITIS AND RETROVIRUS